About 10% of Americans believe they are allergic to penicillin, and approximately 90% of those patients are not actually allergic.
Eisai, Biogen make case for long-term use of Alzheimer’s drug Leqembi with new data
Patients with early Alzheimer’s disease treated with a medication developed by Eisai and Biogen for up to three years experienced less cognitive decline than what’s
July 31, 2024